Discovery of gliotoxin as a new small molecule targeting thioredoxin redox system

Biochemical and Biophysical Research Communications

Volumn 359, Issue 3, 2007, Pages 523-528

  Choi, Hee Shim ^a   Shim, Joong Sup ^a   Kim, Ju A ^b   Kang, Sang Won ^b   Kwon, Ho Jeong ^a  

^a Seoul National University   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Anti angiogenesis; Anti oxidant; Gliotoxin; Thioredoxin redox system

Indexed keywords

GLIOTOXIN; HYDROGEN PEROXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; THIOREDOXIN; WATER;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; OXIDATION; OXIDATION REDUCTION REACTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN TARGETING;

CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; GLIOTOXIN; HUMANS; HYDROGEN PEROXIDE; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; PEROXIDASE; THIOREDOXIN; UMBILICAL CORD;

EID: 34250175495     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.139     Document Type: Article

References (31)

1. Catani M.V., Rossi A., Costanzo A., Sabatini S., Levrero M., Melino G., and Avigliano L. Induction of gene expression via activator protein-1 in the ascorbate protection against UV-induced damage. Biochem. J. 356 (2001) 77-85
2. Bauerova K., and Bezek A. Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis. Gen. Physiol. Biophys. 18 (1999) 15-20
3. Choi M.H., Lee I.K., Kim G.W., Kim B.U., Han Y.H., Yu D.Y., Park H.S., Kim K.Y., Lee J.S., Choi C.H., Bae Y.S., Lee B.I., Rhee S.G., and Kang S.W. Regulation of PDGF signaling and vascular remodeling by peroxiredoxin II. Nature 19 (2005) 347-353
4. Behrend L., Henderson G., and Zwacka R.M. Reactive oxygen species in oncogenic transformation. Biochem. Soc. Trans. 31 (2003) 1441-1444
5. Ridnour L.A., Isenberg J.S., Espey M.G., Thomas D.D., Roberts D.D., and Wink D.A. Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc. Natl. Acad. Sci. USA 102 (2005) 13147-13152
6. Packer L., and Suzuki Y.J. Vitamin E and alpha-lipoate: role in antioxidant recycling and activation of the NF-kappa B transcription factor. Mol. Aspects Med. 14 (1993) 229-239
7. Kim K., Rhee S.G., and Stadtman E.R. Nonenzymatic cleavage of proteins by reactive oxygen species generated by dithiothreitol and iron. J. Biol. Chem. 260 (1985) 15394-15397
8. Chae H.Z., Chung S.J., and Rhee S.G. Thioredoxin-dependent peroxide reductase from yeast. J. Biol .Chem. 269 (1994) 27670-27678
9. Richard J.L., Debey M.C., Chermette R., Pier A.C., Hasegawa A., Lund A., Bratberg A.M., Padhye A.A., and Connole M.D. Advances in veterinary mycology. J. Med. Vet. Mycol. 32 (1994) 169-187
10. Waring P., Sjaarda A., and Lin Q.H. Gliotoxin inactivates alcohol dehydrogenase by either covalent modification or free radical damage mediated by redox cycling. Biochem. Pharmacol. 49 (1995) 1195-1201
11. Hurne A.M., Chai C.L., and Waring P. Inactivation of rabbit muscle creatine kinase by reversible formation of an internal disulfide bond induced by the fungal toxin gliotoxin. J. Biol. Chem. 275 (2000) 25202-25206
12. Pahl H.L., Krauss B., Schulze-Osthoff K., Decher T., Traenckner E.B., Voqt M., Myers C., Parks T., Warring P., Muhlbacher A., Czernilofsky A.P., and Baeurle P.A. The Immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-κB. J. Exp. Med. 183 (1996) 1829-1840
13. Lopez-Franco O., Suzuki Y., Sanjuan G., Blanco J., Hernandez-Vargas P., Yo Y., Kopp J., Egido J., and Gomez-Guerrero C. Nuclear factor-κB inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis. Am. J. Pathol. 161 (2002) 1497-1505
14. Sutton P., Newcombe N.R., Waring P., and Mullbacher A. In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi. Infect. Immun. 62 (1994) 1192-1198
15. Gardiner D.M., Waring P., and Howlett B.J. The epipolythiodioxopiperazine (ETP) class of fungal toxins: distribution, mode of action, functions and biosynthesis. Microbiology 151 (2005) 1021-1032
16. Kim J.A., Park S., Kim K., Rhee S.G., and Kang S.W. Activity assay of mammalian 2-cys peroxiredoxins using yeast thioredoxin reductase system. Anal. Biochem. 338 (2005) 216-223
17. Kang S.W., Chae H.Z., Seo M.S., Kim K., Baines I.C., and Rhee S.G. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α. J. Biol. Chem. 273 (1998) 6297-6302
18. Jeon K.S., Na H.J., Kim Y.M., and Kwon H.J. Antiangiogenic activity of 4-O methylgallic acid from Canavalia gladiata, a dietary legume. Biochem. Biophys. Res. Commun. 330 (2005) 1268-1274
19. Kang S.W., Rhee S.G., Chang T.S., Jeong W., and Choi M.H. 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends Mol. Med. 11 (2005) 571-578
20. LeBel C.P., Ischiropoulos H., and Bondy S.C. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 5 (1992) 227-231
21. Weber W.M., Hunsaker L.A., Abcouwer S.F., Deck L.M., and Vander Jaqt D.L. Anti-oxidant activities of curcumin and related enones. Bioorg. Med. Chem. 13 (2005) 3811-3820
22. Kim J.H., Shim J.S., Lee S.K., Kim K.W., Rha S.Y., Chung H.C., and Kwon H.J. Microarray-based analysis of anti-angiogenic activity of demethoxycurcumin on human umbilical vein endothelial cells: crucial involvement of the down-regulation of matrix metalloproteinase. Jpn. J. Cancer Res. 93 (2002) 1378-1385
23. Kweon Y.O., Paik Y.H., Schnabl B., Qian T., Lemasters J.J., and Brenner D.A. Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. J. Hepatol. 39 (2003) 38-46
24. Huang S.S., and Zheng R.L. Biphasic regulation of angiogenesis by reactive oxygen species. Pharmazie 61 (2006) 223-229
25. Yasuda M., Ohzeki Y., Shimizu S., Naito S., Ohtsuru A., Yamamoto T., and Kuroiwa Y. Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci. 64 (1999) 249-258
26. Neeman M., Gilad A.A., Dafni H., and Cohen B. Molecular imaging of angiogenesis. J. Magn. Reson. Imaging 25 (2007) 1-12
27. Zhao R., Masayasu H., and Holmgren A. Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant. Proc. Natl. Acad. Sci. USA 99 (2002) 8579-8584
28. Eichner R.D., Waring P., Geue A.M., Braithwaite A.W., and Mullbacher A. Gliotoxin causes oxidative damage to plasmid and cellular DNA. J. Biol. Chem. 263 (1988) 3772-3777
29. Niide O., Suzuki Y., Yoshimaru T., Inoue T., Takayama T., and Ra C. Fungal metabolite gliotoxin blocks mast cell activation by a calcium- and superoxide dependent mechanism: implications for immunosuppressive activities. Clin. Immunol. 118 (2006) 108-116
30. Yoshida L.S., Abe S., and Tsunawaki S. Fungal gliotoxin targets the onset of superoxide generating NADPH oxidase of human neutrophils. Biochem. Biophys. Res. Commun. 268 (2000) 716-723
31. Lee H.J., Lee J.H., Hwang B.Y., Kim H.S., and Lee J.J. Anti-angiogenic activities of gliotoxin and its methylthio-derivative, fungal metabolites. Arch. Pharm. Res. 24 (2001) 397-401